1. Legal requirement: Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol
Management of serious breaches of clinical trials authorised in the Europe Union (EU)/ European Economic Area (EEA) is defined by Regulation (EU) No 536/2014, which states in Article 52:
“1. The sponsor shall notify the Member States concerned about a serious breach of this Regulation or of the version of the protocol applicable at the time of the breach through the EU portal without undue delay but not later than seven days of becoming aware of that breach.
2. For the purposes of this Article, a ‘serious breach’ means a breach likely to affect to a significant degree the safety and rights of a subject or the reliability and robustness of the data generated in the clinical trial.”
© European Medicines Agency, 2021
Clinical Research News
Upcoming Clinical Research Training and Conferences
-
on demandACROSS Global Training AcademyOnline
-
29 September 2023 – 02 October 2024SCDM (Society of Clinical Data Management)United States
-
21 – 23 May 2024InformaBelgium
-
03 – 04 June 2024The Society for Clinical Research Sites (SCRS)United States
-
16 – 17 July 2024The Society for Clinical Research Sites (SCRS)Australia
-
27 September – 29 October 2024The Society for Clinical Research Sites (SCRS)United States
Tulevat kliiniset tutkimukset
-
Case Comprehensive Cancer CenterEi vielä rekrytointiaEpiteelin munasarjasyöpä
-
University of California, San FranciscoAmerican Society of TransplantationRekrytointiPediatriset KAIKKI | Maksansiirto; KomplikaatiotYhdysvallat
-
University of California, San DiegoMayo Clinic; National Heart, Lung, and Blood Institute (NHLBI); Yale University ja muut yhteistyökumppanitRekrytointiKeskivaikea tai vaikea astmaYhdysvallat
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); New Mexico State University; National Cancer...Ei vielä rekrytointiaTupakointiin liittyvä karsinoomaYhdysvallat
-
Diabetes Foundation, IndiaNational Diabetes Obesity and Cholesterol FoundationRekrytointiTyypin 2 diabetes, johon liittyy komplikaatioitaIntia
-
Bandırma Onyedi Eylül UniversityEi vielä rekrytointia
-
Centre Hospitalier Universitaire de Saint EtienneLEO Pharma; Ligue contre le cancer, France; Diagnostica StagoEi vielä rekrytointiaSyöpä | Tromboosi | KeuhkoveritulppaRanska
-
Massachusetts General HospitalEi vielä rekrytointiaSkitsofreniaYhdysvallat
-
Aswan UniversityRekrytointiDeksmedetomidiini | Erector Spinae BlockEgypti
-
University Hospital TuebingenRekrytointiPehmytkudossarkooma aikuisilleSaksa
-
Tolmar Inc.ICON plcEi vielä rekrytointia
-
Peking University First HospitalRekrytointi